2022
DOI: 10.1016/j.vgie.2022.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Novel articulating through-the-scope traction device

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 7 publications
0
9
0
Order By: Relevance
“…(e) Use of a double-channel endoscope A double-channel scope combined with the use of forceps, including rotatable devices such as the TracMotion (Fujifilm), can also be used to provide modifiable traction during ESD [63].…”
Section: Distal Attachment Capmentioning
confidence: 99%
“…(e) Use of a double-channel endoscope A double-channel scope combined with the use of forceps, including rotatable devices such as the TracMotion (Fujifilm), can also be used to provide modifiable traction during ESD [63].…”
Section: Distal Attachment Capmentioning
confidence: 99%
“…By contrast, adaptive traction devices mimic a real hand and can modify the traction force as the procedure progresses (figure 3). However, available devices, such as the Endolifter (Olympus) [13] and Trac motion (Fujifilm, Tokyo, Japan) [14], are not independent of the 7 This article is protected by copyright. All rights reserved.…”
Section: Discussionmentioning
confidence: 99%
“…3). However, available devices, such as the Endolifter (Olympus) [13] and TracMotion (Fujifilm, Tokyo, Japan) [14], are not independent of the scope (i. e., they move when the scope moves). Robotic endoscopes provide an independent hand with movement but are very expensive and are limited to developmental units [15].…”
Section: Patient Characteristicsmentioning
confidence: 99%
“…Compared with the standard technique, traction‐assisted ER can achieve shorter procedure time, higher R0 resection, and lower perforation rates 1 . This report presents an ER for a subepithelial gastric tumor using a novel through‐the‐scope (TTS) traction device 2,3 . A 47‐year‐old woman presented with dyspepsia for 3 months.…”
Section: Brief Explanationmentioning
confidence: 99%